Biblio

Export 14 results:
Author Title [ Type(Asc)] Year
Filters: Author is Perry, George  [Clear All Filters]
Journal Article
S. L. Siedlak, Jiang, Y., Huntley, M. L., Wang, L., Gao, J., Xie, F., Liu, J., Su, B., Perry, G., and Wang, X., “TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1027-1033, 2017.
R. J. Castellani and Perry, G., “Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges.”, J Alzheimers Dis, vol. 67, no. 2, pp. 447-467, 2019.
R. H. L. H. Rueli, Torres, D. J., Dewing, A. S. T., Kiyohara, A. C., Barayuga, S. M., Bellinger, M. T., Uyehara-Lock, J. H., White, L. R., Moreira, P. I., Berry, M. J., Perry, G., and Bellinger, F. P., “Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.”, J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
T. Yan, Wang, L., Gao, J., Siedlak, S. L., Huntley, M. L., Termsarasab, P., Perry, G., Chen, S. G., and Wang, X., “Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 1, pp. 157-165, 2018.
M. A. Smith, Bowen, R. L., Nguyen, R. Q., Perry, G., Atwood, C. S., and Rimm, A. A., “Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1269-1277, 2018.
C. S. Atwood and Perry, G., “Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?”, J Alzheimers Dis, vol. 92, no. 3, pp. 799-801, 2023.
L. Calderón-Garcidueñas, Kavanaugh, M., Block, M., D'Angiulli, A., Delgado-Chávez, R., Torres-Jardón, R., González-Maciel, A., Reynoso-Robles, R., Osnaya, N., Villarreal-Calderon, R., Guo, R., Hua, Z., Zhu, H., Perry, G., and Diaz, P., “Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults.”, J Alzheimers Dis, vol. 28, no. 1, pp. 93-107, 2012.
G. L. Iverson, C Keene, D., Perry, G., and Castellani, R. J., “The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features.”, J Alzheimers Dis, vol. 61, no. 1, pp. 17-28, 2018.
M. Liu, Wang, L., Gao, J., Dong, Q., Perry, G., Ma, X., and Wang, X., “Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.”, J Alzheimers Dis, vol. 69, no. 4, pp. 1077-1087, 2019.
V. Vasquez, Mitra, J., Perry, G., Rao, K. S., and Hegde, M. L., “An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1.”, J Alzheimers Dis, vol. 66, no. 2, pp. 453-460, 2018.
M. Ángel Ontiveros-Torres, Labra-Barrios, M. Luisa, Díaz-Cintra, S., Aguilar-Vázquez, A. Ruth, Moreno-Campuzano, S., Flores-Rodríguez, P., Luna-Herrera, C., Mena, R., Perry, G., Florán-Garduño, B., Luna-Muñoz, J., and Luna-Arias, J. Pedro, “Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.”, J Alzheimers Dis, vol. 52, no. 1, pp. 243-69, 2016.
M. Reale, D'Angelo, C., Costantini, E., Di Nicola, M., Yarla, N. Sastry, Kamal, M. Amjad, Salvador, N., and Perry, G., “Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 62, no. 1, pp. 467-476, 2018.
R. J. Castellani and Perry, G., “Dementia Pugilistica Revisited.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1209-1221, 2017.
K. P. Kepp, Sensi, S. L., Johnsen, K. B., Barrio, J. R., Høilund-Carlsen, P. F., Neve, R. L., Alavi, A., Herrup, K., Perry, G., Robakis, N. K., Vissel, B., and Espay, A. J., “The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.”, J Alzheimers Dis, vol. 94, no. 2, pp. 497-507, 2023.